Clinical Trial: Metabolic-Immune Regulatory Mechanisms in Hepatocellular Carcinoma Metastasis and Recurrence and Their Targeted Intervention Strategies (China)

Posted On: 2026-08-21

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Metabolic-Immune Regulatory Mechanisms in Hepatocellular Carcinoma Metastasis and Recurrence and Their Targeted Intervention Strategies'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130367

Registration Time: 2026/08/19

Type: Observational study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337559

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Metabolic-Immune Regulatory Mechanisms in Hepatocellular Carcinoma Metastasis and Recurrence and Their Targeted Intervention Strategies (China)